Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension study*

By Philipp Thomas   Glazer Robert D.   Zhao Yanxing   Pospiech Rainer  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 187-193

Informa Healthcare

Access to resources Recommend Favorite

A long-term, open-label extension study on the safety of treatment with lanthanum carbonate, a new phosphate binder, in patients receiving hemodialysis

By Finn William F.   Joy Melanie S.    

Current Medical Research and Opinion, Vol. 21, Iss. 5, 2005-05 ,pp. : 657-664

Informa Healthcare

Access to resources Recommend Favorite

Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’’s disease in children: REACH open-label extension

By Hyams Jeffrey   Walters Thomas D.   Crandall Wallace   Kugathasan Subra   Griffiths Anne   Blank Marion   Johanns Jewel   Lang Yinghua   Markowitz James   Cohen Stanley   Winter Harland S.   Veereman-Wauters Gigi   Ferry George   Baldassano Robert  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 651-662

Informa Healthcare

Access to resources Recommend Favorite

Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain

By Pascual Maria Luz G.   Fleming Rosa Rosanna B.   Gana Theophilus J.   Vorsanger Gary J.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2531-2542

Informa Healthcare

Access to resources Recommend Favorite

Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability

By Montgomery Stuart   Emir Birol   Haswell Hannah   Prieto Rita  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1223-1230

Informa Healthcare

Access to resources Recommend Favorite